Diet Impact on Colon Cancer Risk
Trial Summary
What is the purpose of this trial?
This trial studies how two different diets affect gut bacteria in African Americans at higher risk for colorectal cancer. One diet is high in red meat and fats, while the other is plant-based and low in fats. Researchers aim to see if these diets change gut bacteria to produce harmful substances that could increase cancer risk.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you regularly take medications that interfere with digestion, use antibiotics within the past 2 months, or take anticoagulants.
What data supports the effectiveness of the treatment High taurine and saturated fat diet, Low in taurine and saturated fat diet for reducing colon cancer risk?
Research suggests that a high intake of saturated fat is linked to an increased risk of colon cancer, while reducing saturated fat intake may lower this risk. Additionally, diets high in fiber are associated with a decreased risk of colon cancer, indicating that dietary changes can influence cancer risk.12345
Is a diet high in taurine and saturated fat safe for humans?
Research suggests that high intake of saturated fats may increase the risk of colon cancer, especially in individuals with a high genetic risk. However, some studies in animal models indicate that high saturated fat content might reduce inflammation and tumor growth, but these findings are not directly applicable to humans.35678
How does the treatment 'High taurine and saturated fat diet, Low in taurine and saturated fat diet' differ from other treatments for colon cancer?
This treatment is unique because it focuses on dietary modifications, specifically the levels of taurine and saturated fat, to potentially influence colon cancer risk, unlike traditional treatments that may involve surgery, chemotherapy, or radiation. The research suggests that dietary fat type and amount can impact colon cancer development, making this approach novel by targeting diet as a preventive measure.2391011
Research Team
H. Rex Gaskins, PhD
Principal Investigator
University of Illinois at Urbana-Champaign
Jason Ridlon, PhD
Principal Investigator
University of Illinois at Urbana-Champaign
Lisa Tussing-Humphreys, PhD, MS, RD
Principal Investigator
University of Illinois at Chicago
Ece Mutlu, MD, MS, MBA
Principal Investigator
Rush University Medical Center
Eligibility Criteria
This trial is for African American adults aged 45-75, who are obese (BMI 30-50), at increased risk for colorectal cancer due to having multiple polyps or a large one in the past five years. They should be generally healthy, post-menopausal if female, and have high C-reactive protein levels. Exclusions include other races, current serious illnesses including heart or kidney disease, recent antibiotic use, and those on diets that affect digestion.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Diet Intervention
Participants undergo a controlled crossover diet intervention with two isocaloric diets: a high taurine and saturated fat diet and a low taurine and saturated fat diet, each for 3 weeks.
Follow-up
Participants are monitored for changes in colonocyte proliferation, mucosal abundance of bacterial genes, bile acid metabolism, serum bile acids, colonic mucosal inflammation, and DNA damage.
Treatment Details
Interventions
- High taurine and saturated fat diet
- Low in taurine and saturated fat diet
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Illinois at Chicago
Lead Sponsor
Rush University Medical Center
Collaborator
National Cancer Institute (NCI)
Collaborator